نتایج جستجو برای: nephrogenic systemic fibrosis

تعداد نتایج: 281042  

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007
Peter Marckmann Lone Skov Kristian Rossen James Goya Heaf Henrik S Thomsen

BACKGROUND Nephrogenic systemic fibrosis may be caused by gadolinium (Gd)-containing magnetic resonance imaging contrast agents. Most reported cases were associated with one particular agent, gadodiamide. Yet, unidentified cofactors might explain why only a minority of renal failure patients exposed to gadodiamide develop nephrogenic systemic fibrosis. METHODS We conducted a case-control stud...

Journal: :Journal of the Formosan Medical Association 2008

Journal: :Journal of Magnetic Resonance Imaging 2009

Journal: :Journal of Magnetic Resonance Imaging 2009

Journal: :Indian Journal of Dermatology 2011

2010

In these patients, avoid use of gadolinium-based contrast agents unless the diagnostic information is essential and not available with non-contrast enhanced magnetic resonance imaging (MRI). NSF may result in fatal or debilitating systemic fibrosis affecting the skin, muscle and internal organs. Screen all patients for renal dysfunction by obtaining a history and/or laboratory tests. When admin...

2011
Arpita Aggarwal Allison A Froehlich Paulina Essah Nooshin Brinster Whitney A High Robert W Downs

INTRODUCTION Nephrogenic systemic fibrosis is a condition that has recently been recognized in patients with chronic renal disease and is associated with use of gadolinium-based contrast agents of ubiquitous use in magnetic resonance imaging scans. The condition is believed to arise through inadequate renal clearance of the gadolinium-based contrast agents, resulting in bodily deposition of the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید